Zhejiang Chemsyn Pharm CoBJSE:920656 36 ROE % is 11.26% as of Mar. 2026, which is 61% below its 10-year median of 29.10. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 55.56% on this metric.
The historical rank and industry rank for Zhejiang Chemsyn Pharm Co's ROE % or its related term are showing as below:
BJSE:920656'
s ROE % Range Over the Past 10 Years
Min: 7.41 Med: 29.1 Max: 66.4
Current: 11.09
During the past 12 years, Zhejiang Chemsyn Pharm Co's highest ROE % was 66.40%. The lowest was 7.41%. And the median was 29.10%.
BJSE:920656's ROE % is ranked better than 55.56% of 18
companies
in the Healthcare Plans industry
Industry Median: 8.165
vs BJSE:920656: 11.09
Zhejiang Chemsyn Pharm Co (BJSE:920656) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co ROE % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's ROE % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a ROE % of 11.26% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is 61% below median its historical median of 29.10. Over the past decade, Zhejiang Chemsyn Pharm Co's ROE % has ranged from 7.41 to 66.40. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 18 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is Zhejiang Chemsyn Pharm Co's ROE % too high?
Zhejiang Chemsyn Pharm Co's current ROE % of 11.26% is 61% below median its 10-year median of 29.10. Over the past 10 years, this metric has ranged from a low of 7.41 to a high of 66.40. The Healthcare Plans industry median ROE % is 8.17. Zhejiang Chemsyn Pharm Co's value of 11.26% is 37.9% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's ROE % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 18 companies for ROE %. This puts Zhejiang Chemsyn Pharm Co in the upper half of its industry. The industry median ROE % is 8.17. Zhejiang Chemsyn Pharm Co's value of 11.26% is 37.9% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own ROE % has ranged from 7.41 to 66.40 over the past decade. While the company's 10-year median is 29.10 vs. the industry median of 8.17, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Plans company?
The median ROE % among Healthcare Plans companies is 8.17, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current ROE % of 11.26% is 37.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median ROE % is 8.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current ROE % is 11.26%, which is 61% below median its own 10-year median of 29.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current ROE % of 11.26%. The current ROE % is 11.26%, which is 61% below median its 10-year median of 29.10 and 37.9% above the Healthcare Plans industry median of 8.17. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current ROE % is 11.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
